{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:17:01Z","timestamp":1784625421681,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Macrodactyly is a disabling congenital disease characterized by overgrowth of soft tissues and bones, which leads to finger enlargement and joint deformity. The mechanism of bone overgrowth in macrodactyly was rarely understood. In our study bone manifestations of three macrodactyly patients were analyzed by micro-CT. <jats:italic>PIK3CA<\/jats:italic> mutation was detected by next-generation sequencing (NGS) of a tumor gene-panel. The PI3K\/AKT\/mTOR pathway activation and target genes were analyzed. The osteogenic potential of macrodactyly-derived bone marrow mesenchymal stem cells (MAC-BMSCs) was compared with polydactyly-derived bone marrow mesenchymal stem cells (PD-BMSCs). <jats:italic>PIK3CA<\/jats:italic> inhibitors were tested for proliferation and osteogenesis potential of MAC-BMSCs. Activating <jats:italic>PIK3CA<\/jats:italic> mutations and activation of PI3K\/AKT\/mTOR pathway were detected in all MAC-BMSCs. MAC-BMSCs had enhanced osteogenesis potential compared with PD-BMSCs. <jats:italic>PIK3CA<\/jats:italic> knockdown by shRNA or BYL719 treatment significantly reduced osteogenic differentiation capacity of MAC-BMSCs. RNA-Seq and qRT-PCR revealed the upregulation of distal-less homeobox 5 (<jats:italic>DLX5<\/jats:italic>) in MAC-BMSCs compared with PD-BMSCs. The osteogenic potential of MAC-BMSCs was inhibited by <jats:italic>DLX5<\/jats:italic> knockdown, indicating that <jats:italic>DLX5<\/jats:italic> is a downstream target of <jats:italic>PIK3CA<\/jats:italic> activation-mediated osteogenesis. This study revealed that osteogenic differentiation in MAC-BMSCs is enhanced by <jats:italic>PIK3CA<\/jats:italic> activation mutation through PI3K\/AKT\/mTOR signaling pathway and can be reversed by <jats:italic>PIK3CA<\/jats:italic> knockdown or drug inhibition.<\/jats:p>","DOI":"10.1038\/s41419-020-2723-6","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T10:03:59Z","timestamp":1594029839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Activating PIK3CA mutation promotes osteogenesis of bone marrow mesenchymal stem cells in macrodactyly"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-3632","authenticated-orcid":false,"given":"Hengqing","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7940-1223","authenticated-orcid":false,"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"2723_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00000478-198501000-00004","volume":"9","author":"TA Silverman","year":"1985","unstructured":"Silverman, T. A. & Enzinger, F. M. Fibrolipomatous hamartoma of nerve. A clinicopathologic analysis of 26 cases. Am. J. Surg. Pathol. 9, 7\u201314 (1985).","journal-title":"Am. J. Surg. Pathol."},{"key":"2723_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200183","volume":"13","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. Morphological and neurophysiological impairment of the nerve in type II macrodactyly. PLoS ONE 13, e0200183 (2018).","journal-title":"PLoS ONE"},{"key":"2723_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41379-019-0354-1","volume":"33","author":"PR Blackburn","year":"2020","unstructured":"Blackburn, P. R. et al. PIK3CA mutations in lipomatosis of nerve with or without nerve territory overgrowth. Mod. Pathol. 33, 420\u2013430 (2020).","journal-title":"Mod. Pathol."},{"key":"2723_CR4","doi-asserted-by":"publisher","first-page":"12e","DOI":"10.1097\/01.prs.0000436822.26709.7c","volume":"133","author":"RA Maclellan","year":"2014","unstructured":"Maclellan, R. A. et al. PIK3CA activating mutations in facial infiltrating lipomatosis. Plast. Reconstr. Surg. 133, 12e\u201319e (2014).","journal-title":"Plast. Reconstr. Surg."},{"key":"2723_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/17453676708989619","volume":"38","author":"K Rechnagel","year":"1967","unstructured":"Rechnagel, K. Megalodactylism. Report of 7 cases. Acta Orthopaedica Scandinavica 38, 57\u201366 (1967).","journal-title":"Acta Orthopaedica Scandinavica"},{"key":"2723_CR6","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.jhsa.2013.08.095","volume":"38","author":"F Cerrato","year":"2013","unstructured":"Cerrato, F. et al. Presentation and treatment of macrodactyly in children. J. Hand Surg. 38, 2112\u20132123 (2013).","journal-title":"J. Hand Surg."},{"key":"2723_CR7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1172\/JCI70050","volume":"124","author":"JL Crane","year":"2014","unstructured":"Crane, J. L. & Cao, X. Bone marrow mesenchymal stem cells and TGF-beta signaling in bone remodeling. J. Clin. Invest. 124, 466\u2013472 (2014).","journal-title":"J. Clin. Invest."},{"key":"2723_CR8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi, M. Skeletal remodeling in health and disease. Nat. Med. 13, 791\u2013801 (2007).","journal-title":"Nat. Med."},{"key":"2723_CR9","doi-asserted-by":"publisher","first-page":"11090","DOI":"10.1038\/s41598-017-11666-3","volume":"7","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. Altered adipose-derived stem cell characteristics in macrodactyly. Sci. Rep. 7, 11090 (2017).","journal-title":"Sci. Rep."},{"key":"2723_CR10","doi-asserted-by":"publisher","first-page":"B224","DOI":"10.1093\/geronj\/49.5.B224","volume":"49","author":"MR Benedict","year":"1994","unstructured":"Benedict, M. R. et al. Dissociation of bone mineral density from age-related decreases in insulin-like growth factor-I and its binding proteins in the male rat. J. Gerontol. 49, B224\u2013B230 (1994).","journal-title":"J. Gerontol."},{"key":"2723_CR11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1084\/jem.20150407","volume":"212","author":"MB Greenblatt","year":"2015","unstructured":"Greenblatt, M. B. et al. CHMP5 controls bone turnover rates by dampening NF-kappaB activity in osteoclasts. J. Exp. Med. 212, 1283\u20131301 (2015).","journal-title":"J. Exp. Med."},{"key":"2723_CR12","first-page":"3505","volume":"19","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. TGFbeta1 promotes the osteoinduction of human osteoblasts via the PI3K\/AKT\/mTOR\/S6K1 signalling pathway. Mol. Med. Rep. 19, 3505\u20133518 (2019).","journal-title":"Mol. Med. Rep."},{"key":"2723_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/hmg\/dds440","volume":"22","author":"JJ Rios","year":"2013","unstructured":"Rios, J. J. et al. Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly. Hum. Mol. Genet. 22, 444\u2013451 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"2723_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0092-8674(92)90166-A","volume":"70","author":"ID Hiles","year":"1992","unstructured":"Hiles, I. D. et al. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70, 419\u2013429 (1992).","journal-title":"Cell"},{"key":"2723_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1126\/science.279.5351.710","volume":"279","author":"L Stephens","year":"1998","unstructured":"Stephens, L. et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710\u2013714 (1998).","journal-title":"Science"},{"key":"2723_CR16","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1158\/0008-5472.CAN-04-4114","volume":"65","author":"T Ikenoue","year":"2005","unstructured":"Ikenoue, T. et al. Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res. 65, 4562\u20134567 (2005).","journal-title":"Cancer Res."},{"key":"2723_CR17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1073\/pnas.0408864102","volume":"102","author":"S Kang","year":"2005","unstructured":"Kang, S., Bader, A. G. & Vogt, P. K. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc. Natl Acad. Sci. USA 102, 802\u2013807 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2723_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccr.2005.05.014","volume":"7","author":"Y Samuels","year":"2005","unstructured":"Samuels, Y. et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561\u2013573 (2005).","journal-title":"Cancer Cell"},{"key":"2723_CR19","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ccell.2017.04.013","volume":"31","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. A pan-cancer proteogenomic atlas of PI3K\/AKT\/mTOR pathway alterations. Cancer Cell 31, 820\u2013832 e823 (2017).","journal-title":"Cancer Cell"},{"key":"2723_CR20","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ng.2332","volume":"44","author":"MJ Lindhurst","year":"2012","unstructured":"Lindhurst, M. J. et al. Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat. Genet. 44, 928\u2013933 (2012).","journal-title":"Nat. Genet."},{"key":"2723_CR21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","volume":"558","author":"Q Venot","year":"2018","unstructured":"Venot, Q. et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 558, 540 (2018).","journal-title":"Nature"},{"key":"2723_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.stem.2012.02.003","volume":"10","author":"D Park","year":"2012","unstructured":"Park, D. et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 10, 259\u2013272 (2012).","journal-title":"Cell Stem Cell"},{"key":"2723_CR23","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1038\/cdd.2015.99","volume":"22","author":"H Li","year":"2015","unstructured":"Li, H. et al. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K\/AKT pathway. Cell Death Differ. 22, 1935\u20131945 (2015).","journal-title":"Cell Death Differ."},{"key":"2723_CR24","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1073\/pnas.0604153104","volume":"104","author":"X Liu","year":"2007","unstructured":"Liu, X. et al. Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc. Natl Acad. Sci. USA 104, 2259\u20132264 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2723_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1904-7","volume":"10","author":"C Ye","year":"2019","unstructured":"Ye, C. et al. Extracellular IL-37 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via activation of the PI3K\/AKT signaling pathway. Cell Death Dis. 10, 753 (2019).","journal-title":"Cell Death Dis."},{"key":"2723_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jcp.21200","volume":"213","author":"AI Caplan","year":"2007","unstructured":"Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell Physiol. 213, 341\u2013347 (2007).","journal-title":"J. Cell Physiol."},{"key":"2723_CR27","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/cdd.2017.110","volume":"24","author":"Q Dai","year":"2017","unstructured":"Dai, Q. et al. mTOR\/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression. Cell Death Differ. 24, 1886\u20131899 (2017).","journal-title":"Cell Death Differ."},{"key":"2723_CR28","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1242\/dev.137075","volume":"143","author":"JS Yu","year":"2016","unstructured":"Yu, J. S. & Cui, W. Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination. Development 143, 3050\u20133060 (2016).","journal-title":"Development"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2723-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2723-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2723-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:25:47Z","timestamp":1760084747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2723-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["2723"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2723-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"8 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"505"}}